Fund Holdings — DIADEMA PARTNERS LP

Total Portfolio Value:
$143.56M
Total Bought:
$74.51M
Total Sold:
$93.38M
Net Transaction:
-$18.87M
Notable People:
Timothy Beau Bassett
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Regeneron Pharmaceuticals, Inc.(REGN)5,60730,160+24,553$2.94M$16.96M11.81%+$14.01M
Soleno Therapeutics Inc284,152177,330-106,822$23.81M$11.99M8.35%-$11.82M
BioMarin Pharmaceutical Inc.(BMRN)192,877212,877+20,000$10.60M$11.53M8.03%+$927.0K
Vaxcyte, Inc.(PCVX)198,285218,285+20,000$6.45M$7.86M5.48%+$1.42M
Indivior Plc0254,252+254,252$0$6.13M4.27%+$6.13M
Bristol-Myers Squibb Company(BMY)0130,000+130,000$0$5.86M4.08%+$5.86M
Ascendis Pharma A/SADR(ASND)027,572+27,572$0$5.48M3.82%+$5.48M
Neurocrine Biosciences, Inc.(NBIX)94,04237,754-56,288$11.82M$5.30M3.69%-$6.52M
Viking Therapeutics, Inc.(VKTX)197,468193,689-3,779$5.23M$5.09M3.55%-$142.8K
Alnylam Pharmaceuticals, Inc.(ALNY)010,000+10,000$0$4.56M3.18%+$4.56M
Immunocore Holdings plcADS(IMCR)104,384124,384+20,000$3.28M$4.52M3.15%+$1.24M
Nektar Therapeutics(NKTR)075,000+75,000$0$4.27M2.97%+$4.27M
ABIVAX Société AnonymeADS(ABVX)041,620+41,620$0$3.51M2.45%+$3.51M
Protagonist Therapeutics Inc76,18551,185-25,000$4.21M$3.40M2.37%-$810.5K
Jazz Pharmaceuticals plcSHS USD(JAZZ)104,47323,140-81,333$11.09M$3.05M2.12%-$8.04M
ANI Pharmaceuticals, Inc.(ANIP)031,400+31,400$0$2.88M2.00%+$2.88M
Revolution Medicines, Inc.(RVMD)79,07959,079-20,000$2.91M$2.76M1.92%-$150.3K
Apogee Therapeutics Inc10,57264,250+53,678$459.1K$2.55M1.78%+$2.09M
Terns Pharmaceuticals Inc259,852323,159+63,307$969.2K$2.43M1.69%+$1.46M
Ardelyx Inc0400,000+400,000$0$2.20M1.54%+$2.20M
TG Therapeutics, Inc.(TGTX)371,44860,748-310,700$13.37M$2.19M1.53%-$11.17M
Alkermes plcSHS(ALKS)072,079+72,079$0$2.16M1.51%+$2.16M
Roivant Sciences Ltd.SHS(ROIV)0120,000+120,000$0$1.82M1.26%+$1.82M
UroGen Pharma Ltd.(URGN)150,00090,000-60,000$2.06M$1.80M1.25%-$259.5K
Pacira BioSciences, Inc.(PCRX)58,92658,9260$1.41M$1.52M1.06%+$110.2K
Cogent Biosciences, Inc.(COGT)392,21397,813-294,400$2.82M$1.40M0.98%-$1.41M
Novo Nordisk A/SADR(NVO)025,000+25,000$0$1.39M0.97%+$1.39M
Harmony Biosciences Holdings, Inc.(HRMY)050,000+50,000$0$1.38M0.96%+$1.38M
Amylyx Pharmaceuticals, Inc.(AMLX)0100,000+100,000$0$1.36M0.95%+$1.36M
Avidity Biosciences Inc030,000+30,000$0$1.31M0.91%+$1.31M
Mind Medicine Mindmed Inc158,536105,891-52,645$1.03M$1.25M0.87%+$219.6K
Vistagen Therapeutics, Inc.(VTGN)403,922349,789-54,133$807.8K$1.24M0.86%+$433.9K
MannKind Corporation(MNKD)0212,475+212,475$0$1.14M0.79%+$1.14M
Supernus Pharmaceuticals, Inc.(SUPN)022,348+22,348$0$1.07M0.74%+$1.07M
Catalyst Pharmaceuticals Inc050,000+50,000$0$985.0K0.69%+$985.0K
Reviva Pharmaceutcls Hldgs I2,735,4572,506,921-228,536$1.04M$924.1K0.64%-$118.4K
Arcturus Therapeutics Holdings Inc.(ARCT)048,811+48,811$0$899.6K0.63%+$899.6K
Trevi Therapeutics, Inc.(TRVI)185,83085,830-100,000$1.02M$785.3K0.55%-$231.1K
Xeris Biopharma Holdings Inc074,753+74,753$0$608.5K0.42%+$608.5K
CytomX Therapeutics, Inc.(CTMX)0185,286+185,286$0$591.1K0.41%+$591.1K
Moderna, Inc.(MRNA)020,000+20,000$0$516.6K0.36%+$516.6K
Aytu Biopharma Inc0272,670+272,670$0$512.6K0.36%+$512.6K
Tenaya Therapeutics, Inc.(TNYA)0315,519+315,519$0$511.1K0.36%+$511.1K
Equillium, Inc.(EQ)0300,000+300,000$0$429.0K0.30%+$429.0K
Alector Inc266,023136,023-130,000$372.4K$402.6K0.28%+$30.2K
Proqr Thrapeutics N VSHS EURO
SHS EURO
157,694157,6940$321.7K$335.9K0.23%+$14.2K
Pyxis Oncology, Inc.(PYXS)0150,000+150,000$0$333.0K0.23%+$333.0K
Pelthos Therapeutics Inc.(PTHS)010,498+10,498$0$293.9K0.20%+$293.9K
Ultragenyx Pharmaceutical Inc.(RARE)53,9859,189-44,796$1.96M$276.4K0.19%-$1.69M
Climb Bio, Inc.(CLYM)702,135136,488-565,647$870.6K$274.3K0.19%-$596.3K
Neuphoria Therapeutics Inc021,452+21,452$0$252.9K0.18%+$252.9K
Foghorn Therapeutics Inc.(FHTX)050,000+50,000$0$244.5K0.17%+$244.5K
Ovid Therapeutics Inc.(OVID)0187,739+187,739$0$244.1K0.17%+$244.1K
Relay Therapeutics, Inc.(RLAY)43,61643,6160$150.9K$227.7K0.16%+$76.8K
Ventyx Biosciences Inc071,204+71,204$0$221.4K0.15%+$221.4K
PureTech Health plcADS(PRTCY)7,3247,3240$126.3K$135.5K0.09%+$9.2K
Anaptysbio Inc03,295+3,295$0$100.9K0.07%+$100.9K
Tvardi Therapeutics, Inc.(TVRD)02,185+2,185$0$85.1K0.06%+$85.1K
PMV Pharmaceuticals, Inc.(PMVP)011,300+11,300$0$15.8K0.01%+$15.8K
89bio Inc98,3820-98,382$966.1K$0—-$966.1K
Amgen Inc.(AMGN)52,1000-52,100$14.55M$0—-$14.55M
Arvinas, Inc.(ARVN)96,4550-96,455$709.9K$0—-$709.9K
Eledon Pharmaceuticals, Inc.(ELDN)64,6130-64,613$175.1K$0—-$175.1K
Elevation Oncology Inc362,9350-362,935$133.2K$0—-$133.2K
Eli Lilly and Company(LLY)14,8160-14,816$11.55M$0—-$11.55M
Gilead Sciences, Inc.(GILD)30,0000-30,000$3.33M$0—-$3.33M
Iteos Therapeutics Inc206,2000-206,200$2.06M$0—-$2.06M
Merck & Co., Inc.(MRK)20,0000-20,000$1.58M$0—-$1.58M
Nuvalent Inc5,0000-5,000$381.5K$0—-$381.5K
Olema Pharmaceuticals, Inc.(OLMA)253,6570-253,657$1.08M$0—-$1.08M
Phathom Pharmaceuticals, Inc.(PHAT)40,2940-40,294$386.4K$0—-$386.4K
Replimune Group, Inc.(REPL)32,4830-32,483$301.8K$0—-$301.8K
Scholar Rock Holding Corporation(SRRK)62,9260-62,926$2.23M$0—-$2.23M
Summit Therapeutics Inc.(SMMT)9320-932$19.8K$0—-$19.8K
Vertex Pharmaceuticals Incorporated(VRTX)10,0000-10,000$4.45M$0—-$4.45M
Viridian Therapeutics, Inc.(VRDN)122,0610-122,061$1.71M$0—-$1.71M
Zai Lab LimitedADR(ZLAB)3,7850-3,785$13.2K$0—-$13.2K
argenx SEADR(ARGX)5,9740-5,974$3.29M$0—-$3.29M
Scpharmaceuticals Inc217,6230-217,623$829.1K$0—-$829.1K
Page 1 of 1
DIADEMA PARTNERS LP — 13F Holdings — Q3 2025 | TickerTrail